| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.09 | 0.08 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.09 | 0.09 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.09 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.079 | 0.09 |